UK Markets closed

Fresenius Medical Care AG & Co. KGaA (FME.DE)

XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
56.30+0.48 (+0.86%)
At close: 05:35PM CEST
Sign in to post a message.
  • S
    Sparky
    Fresenius Medical Care anticipates significant negative impact on 2021 net income from accelerated COVID-19 related excess mortality of dialysis patients; confirms mid-term targets
  • k
    kris
    In with a first position. This will go up again.
  • E
    E A
    Goldman Sachs downgraded this stock last week after it fell more than 10% what this means is you should be buying this hand over fist. $52 by end of Q2 !!!!!
  • E
    E A
    Pfizer, Moderna and J & J all potentially cause blood clots ...blood clots cause kidney damage.....kidney damage result in Dialysis...buy FMS its the cheapest stock in the Universe ! $80 stock by end of 2022 ! Mortality was released in order to tank these stocks so the big boyz load the boat !!!!!
  • A
    Anonymous
    $FMS $FMSPR (Fresenius Medical Care AG & Co)
    Target Set by Jefferies Sell EUR 60
    Target Set by Goldman Sachs Buy EUR 70
  • S
    Sam
    Can you believe that this was at this price 10 years ago????
  • M
    Michael
    Would be great if FMS could leverage their tremendous workforce to administer COVID 19 vaccinations.
  • M
    Mark Williams
    When is Fms going to stop running from the deal they made and Man Up with Akrx?
  • A
    Antony Folden
    is it time to buy ?
  • a
    artifact4727
    Fresenius Medical Care down, because of profit warning due to Covid-19 related issues.
  • M
    Michael
    Extremely oversold now.
  • D
    David
    buy!!!!!!!! hold!!!!! hold!!!!
  • A
    Anonymous
    I’ve been with the company for a couple of years, and just found out it is publicly traded. I could easily assume the returns can’t be good before even checking on it, and I was dead right. I will never be interested in buying this stock
  • M
    Mark Williams
    From investing.com
    From investing.com
    screenshots.firefox.com
  • E
    E A
    FMS making it's move jump on this train ......heading to $42-$44 in the next 6-8 weeks ! EOY $55 to $60 ! CKD is exploding in this country !
  • M
    Michael
    FMS should benefit from unfortunate side effect of COVID-19. Kidney damage and medical findings that for some COVID 19 results in sudden onset of insulin dependent diabetes.
  • J
    Joe
    Why is Abraxane production halted at Melrose Park facility? It contract manufactures to BMS and Beigene. Regulatory issues. Please advise. TomS this is why stock is down.
  • M
    Mitchell
    Why isn’t there any action on this board?
  • B
    Bill
    Not a lot of reason to buy this company other than the dividend.
  • A
    Anonymous
    $FMSPR
    Target Set by JPMorgan Chase Neutral EUR 51.1
    Target Set by Deutsche Bank Neutral EUR 65